Cite
HARVARD Citation
Alamgeer, M. et al. (2012). Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements. Clinical investigation. pp. 895-907. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Alamgeer, M. et al. (2012). Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements. Clinical investigation. pp. 895-907. [Online].